Upgrade to SI Premium - Free Trial

TD Cowen: 'Edwards Lifesciences (EW) Share Gain Story Includes TAVR and TMTT Chapters'

April 17, 2026 9:35 AM
TD Cowen analyst Joshua Jennings reiterated a Buy rating and $97.00 price target on Edwards Lifesciences (NYSE: EW).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments